| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/14/2008 | US20080194512 Compositions and methods for inhibiting viral replication |
| 08/14/2008 | US20080194511 Encoding somatoliberin (GHRH) and comprising a eukaryotic promoter; a 5' untranslated region, a codon-optimized-eukaryotic therapeutic gene sequence, and a polyadenylation signal; plasmid mediated gene supplementation |
| 08/14/2008 | US20080194510 Substances, Compositions and Methods for Preventing and Treating Immune-Mediated Inflammatory Disorders |
| 08/14/2008 | US20080194509 Novel Adenyl Dinucleotides with Antitumour Activity and a Method of preparing Thereof |
| 08/14/2008 | US20080194508 Cell Counting |
| 08/14/2008 | US20080194507 Defibrotide An/Or Oligodeoxyribonucleotides For Treating Angiogenesis-Dependent Tumors |
| 08/14/2008 | US20080194506 Tumors; animal or plant extracts or synthetic DNA; coadministered with a defibrotide, rapamycin, paclitaxel, monocrotaline, BCNU, or cyclophosphamide; angiogenesis inhibitors; breast cancer |
| 08/14/2008 | US20080194505 Point mutations; antibodies; fusion proteins |
| 08/14/2008 | US20080194504 Rna-Mediated Interference to Control Disease in Terrestrial and Aquaculture Animals |
| 08/14/2008 | US20080194503 Antisense Modulation of P38 Mitogen Activated Protein Kinase Expression |
| 08/14/2008 | US20080194502 2' protected nucleoside monomers protected with orthoester-type and acyl carbonate groups; solid phase synthesis of RNA, oxidation and deprotecting, removal from the support |
| 08/14/2008 | US20080194501 Cyclic Bioisosters of Derivatives of a Purine System and Pharmaceutical Composition Based Thereon |
| 08/14/2008 | US20080194500 Preferably polyethylene glycol etherified by an aliphatic alcohol and a perfluorodiol attached to a di-stearoyl glycerophosphatidylethanolamine; improved water solubility and decreased toxicity of paclitaxel, rapamycin, geldanamycin, doxorubicin, or amphotericin B |
| 08/14/2008 | US20080194499 Solvent extraction of a plant extract from Centella asiatica; removing fatty substances and chlorophyll; purification by HPLC; concentrating the eluent to obtain pentacyclic terpenoid glycosides, preferably asiaticoside and madecassoside; obesity |
| 08/14/2008 | US20080194497 Macrolide polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof |
| 08/14/2008 | US20080194496 Preventing DNA impairment and skin wrinkling caused by ultraviolet radiation; cosmetics |
| 08/14/2008 | US20080194495 1-amino-2,3-dihydroxy-5-hydroxymethyl-cyclopent-4-yl 4-O-(6-deoxy- alpha -D-glucopyranosyl)- alpha -D-glucopyranoside; alpha-amylase inhibitor; antidiabetic agents, hypoglycemic agents; side effect reduction |
| 08/14/2008 | US20080194494 4-Biarylyl-1-Phenylazetidin-2-One Glucuronide Derivatives for Hypercholesterolemia |
| 08/14/2008 | US20080194492 Use of gamma-glutamyl-peptide for example gamma-L-glutamyltrans-S-1-propenyl-L-cysteine sulfoxide (GPCS); Paget's disease, tumor-induced bone disease or osteoporosis; ethanolic extract of allium such as Allium cepa (onion); nutraceuticals |
| 08/14/2008 | US20080194491 Methods of Diagnosing, Preventing, and Treating Early Onset of Pulmonary Hypertension |
| 08/14/2008 | US20080194476 Medicament Comprising A Peptide Extract Of Avocado, Which Is Intended For The Treatment And Prevention Of Illnesses That Are Linked To An Immune System Deficiency |
| 08/14/2008 | US20080194472 Use of Fgf-18 Protein, Target Proteins and Their Respective Encoding Nucleotide Sequences to Induce Cartilage Formation |
| 08/14/2008 | US20080194468 Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye |
| 08/14/2008 | US20080194467 Cancer treatment methods using cadherin antagonists in combination with anticancer agents |
| 08/14/2008 | US20080194466 (5Z)-5-(6-Quinoxalinylmethylidene)-2-[(2,4,6-Trichlorophenyl)Amino]-1,3-Thiazol-4(5H)-One |
| 08/14/2008 | US20080194465 Cross-linked glycopeptide-cephalosporin antibiotics |
| 08/14/2008 | US20080194464 Chemical intermediate thereto; effective against antibiotic-resistant strains of bacteria, such as methicillin-resistant Staphylococci aureus (MRSA) |
| 08/14/2008 | US20080194458 Phospholipid, higher alcohol, and higher aliphatic acid; free of protein and peptide; respiratory disorders |
| 08/14/2008 | US20080194457 Frizzled Proteins and Detection and Treatment of Cancer |
| 08/14/2008 | US20080194019 Administering metformin and/or phenformin; for treatment of diabetes and cancer; drug screening |
| 08/14/2008 | US20080193575 Powders or granules containing isoflavone and soy products; fluid flow |
| 08/14/2008 | US20080193574 Central nervous system disorders;Alzheimer's disease; using ginger oil |
| 08/14/2008 | US20080193573 Using supercritical carbon dioxide extraction method; reduce amyloid plaque aggregate; Alzheimer's disease |
| 08/14/2008 | US20080193571 Extraction of sterol and fatty acid using ethanol and water; efficiency |
| 08/14/2008 | US20080193570 Mixture of ethanol, polyol, salicylic acid, triclosan, allantoin, licorice and camphor, salt and plant extracts |
| 08/14/2008 | US20080193568 Polyacetylenic Compounds |
| 08/14/2008 | US20080193564 Method for preventing or reducing secondary fractures after hip fracture |
| 08/14/2008 | US20080193561 For oral administering; mixture of polyunsaturated fatty acid, phospholipids, controller of methionine metabolism such as folic acid, vitamins, minerals, zinc |
| 08/14/2008 | US20080193558 Stabilized and preserved ketotifen ophth almic compositions |
| 08/14/2008 | US20080193556 Mixture containing base alkalizer; absorption by stomach; side effect reduction |
| 08/14/2008 | US20080193550 conjugated linoleic acid; treat, prevent conditions associated with leukocyte infiltration, eosinophilia, IgE secretion, airway remodelling, bronchoconstriction, mucus hypersecretion, asthma; injection, ingestion, inhalation, topical |
| 08/14/2008 | US20080193547 Targeted delivery of drugs; nanodevices allow lower dosage for minimum inhibitory concentration; sandwich structure protects active ingredient to avoid immune reactions; incorporate paramagnetic ions, metals as diagnostic contrast agents for Magnetic Resonance Imaging |
| 08/14/2008 | US20080193544 Taste Masked Dosage Form Containing Roflumilast |
| 08/14/2008 | US20080193542 Ziprasidone mesylate or ziprasidone hydrochloride; nanoparticles less than 2000 nm; carrier; two surface stabilizers; crystallization inhibitors; polyvinylpyrrolidone, Pluronic surfactants; psychosis, schizophrenia; administration via intramuscular or subcutaneous injection |
| 08/14/2008 | US20080193537 Morphine Sulfate Formulations |
| 08/14/2008 | US20080193532 Antibiotic, colloidal silicon dioxide, povidone, silicified microcrystalline cellulose, croscarmellose sodium, magnesium stearate and a coating, Cmax is reached in less than five hours; tuberculosis |
| 08/14/2008 | US20080193531 Proton pump inhibitor, omeprazole, hydroxyomeprazole, esomeprazole, tenatoprazole, lansoprazole; H2 blocker, cimetidine, famotidine, nizatidine, ranitidine; formic, acetic, propionic acid; vitamin C, vitamin A, vitamin E; calcium, chromium, copper minerals; enteric coated; tablet, pill, powder, capsules |
| 08/14/2008 | US20080193530 Use of ranolazine for the treatment of non-coronary microvascular diseases |
| 08/14/2008 | US20080193529 Free-flowing, cohesive tableting powder for direct compressed tablet; DPP-IV inhibitor and glitazone, in unit dosage form; acceptable dissolution profile; acceptable degrees of hardness, resistance to chipping, short disintegration time |
| 08/14/2008 | US20080193528 Bosentan; excipients, filler, lubricant, disintegrant, acidifying agent, flavouring, sweetening; endothelin receptor inhibitor; pulmonary arterial hypertension |
| 08/14/2008 | US20080193527 Pharmaceutical compositions containing quetiapine fumarate |
| 08/14/2008 | US20080193526 Pharmaceutical Compositions Useful in the Treatment of Pain |
| 08/14/2008 | US20080193524 Extended Release Venlafaxine Compositions |
| 08/14/2008 | US20080193523 Composition |
| 08/14/2008 | US20080193521 Hyperphosphatemia in chronic kidney disease or end-stage renal disease patients; nutritional supplements |
| 08/14/2008 | US20080193519 An efflux pump inhibitor (2S)-2-(naphthyl-1-sulphonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid or the ethyl ester and a surfactant; improved intestinal absorption when orally administered |
| 08/14/2008 | US20080193518 3-[2-(3-tert-Butyl-ureido)-3,3-dimethyl-butyryl]-6,6-dimethyl-3-aza-bicyclo[3.1.0]hexane-2-carboxylic acid (2-carbamoyl-1-cyclobutylmethyl-2-oxo-ethyl)-amide; Solvent-anti-solvent precipitation; hepatitis C virus protease inhibitors |
| 08/14/2008 | US20080193517 Polymer Conjugates of K-252A and Derivatives Thereof |
| 08/14/2008 | US20080193516 Oxygen-carrying blood substitute preparations |
| 08/14/2008 | US20080193515 Overexpression of Wnt ligands and treatment of lytic bone diseases |
| 08/14/2008 | US20080193512 Drug Carrier and Drug Carrier Kit for Inhibiting Fibrosis |
| 08/14/2008 | US20080193510 Nucleic acids, peptides, and antibodies for use in diagnosis and therapy; macular degeneration; cancers of the colon, breasts, prostate, liver, pancreas, and mouth; receptor binding assays of the peptide to neovasulatures |
| 08/14/2008 | US20080193509 Liposome Preparation Containing Slightly Water-Soluble Camptothecin |
| 08/14/2008 | US20080193508 Local anti-infective agent for treatment of nail fungal infections |
| 08/14/2008 | US20080193503 Melt extrusion of a mixture of memantine and biodegradable glycolic acid-lactic acid copolymer to make a sustained release implant to last for one week; glaucoma and proliferative vitreoretinopathy; angiogenesis inhibition |
| 08/14/2008 | US20080193502 Memantine intravitreal implants |
| 08/14/2008 | US20080193500 Aggrecan; collagen; heteropolysaccharide in extracellular matrix |
| 08/14/2008 | US20080193499 Inosine-monophosphate dehydrogenase inhibitor, clotrimazole, fluconazole, trifluridine, danazol, and asparaginase; sustained release; kits |
| 08/14/2008 | US20080193498 For reducing, preventing, mitigating, and/or delaying the onset of, attenuating the severity of, and/or hastening the resolution of, chemotherapy-associated toxicities; nucleosides |
| 08/14/2008 | US20080193492 For vaginal dryness |
| 08/14/2008 | US20080193489 Personal Lubricant Compositions That Are Free Of Glycerin and Parabens |
| 08/14/2008 | US20080193488 Variant Polypeptide and Screening Assay |
| 08/14/2008 | US20080193487 Preparation for Vaccination, Vaccination Method and Use of a Vaccination Preparation |
| 08/14/2008 | US20080193481 Synthetic Anti-Candida Albicans Oligosaccharide Based Vaccines |
| 08/14/2008 | US20080193479 Method and Compositions for the Treatment of Hematologic Cancers |
| 08/14/2008 | US20080193468 Method for Stimulating the Immune Response of Newborns |
| 08/14/2008 | US20080193464 Identification of human autism susceptibility gene, which can be used for diagnosis, prevention and treatment of autism; invention discloses that the PRKCB1 gene of chromosome 16 and certain alleles thereof are related to susceptibility to autism and represent novel targets for therapeutic intervention |
| 08/14/2008 | US20080193463 Combating the pathogenic effects of Mycoplasma infection in an animal by administering an effective amount of isolated and purified mycoplasmal L-alpha-glycerophosphate oxidase or an immunogenic fragment thereof, and a pharmaceutically acceptable carrier |
| 08/14/2008 | US20080193462 Inhibiting tumor cell growth in subject by administering to said subject a combination of a cytotoxic or a chemotherapeutic agent and a composition comprising an insulin-like growth factor receptor-1 (IGF-1R) inhibitor; demonstrating specific approaches to enhance therapeutic window of IGF-1R inhibition |
| 08/14/2008 | US20080193459 Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti HSP90 antibodies |
| 08/14/2008 | US20080193456 Glucan conjugated monoclonal antibody for use in treatment and prevention of cell proliferative disorders; antitumor agents |
| 08/14/2008 | US20080193454 Identification of Surface-Associated Antigens for Tumor Diagnosis and Therapy |
| 08/14/2008 | US20080193452 Sulfated nucleoside derivatives including ribonucleoside mono- and disulfates derived from guanine, adenosine, and cytidine |
| 08/14/2008 | US20080193448 Combinations and Methods of Using an Indolinone Compound |
| 08/14/2008 | US20080193444 Methods of suppressing LTP inhibition |
| 08/14/2008 | US20080193440 Method For Multiple Sclerosis Treatment and Prophylaxis By Treatment of Leptospira Infection |
| 08/14/2008 | US20080193437 Two oligonucleotides each containing 2'-deoxy-7-deazaguanosine and linked by a non-nucleotide linker and where the sequences are at least partially self-complementary; anticarcinogenic agents; antiinflammatory agents; autoimmune diseases; antiallergens asthma; disease; gene therapy; vertabrates |
| 08/14/2008 | US20080193432 Alpha -tocopherol, hydro-Q9 chromene, coenzyme Q9, cycloartane, 1-Feruloyl glycerol; activates estrogen receptors; improving menopause symptoms |
| 08/14/2008 | US20080193428 Benzoic acid or its sodium salt, saccharide, bactericide or antibiotic; glucose, fructose, mannose water-soluble gels, capsules; cleaning product, deodorizing agent |
| 08/14/2008 | US20080193425 Methods for administering fgf18 |
| 08/14/2008 | US20080193423 Small organic molecule regulators of cell proliferation |
| 08/14/2008 | US20080193416 Vectors used to generate modified artificial chromosomes; cleavage sites that flank origin of replication, antibiotic resistance gene and sequence that encodes fluorescent protein |
| 08/14/2008 | US20080193414 Use of an Immunoglobulin Domain-Containing Cell Surface Recognition Molecule For Treating Diseases |
| 08/14/2008 | US20080193413 Anti-Infective Agents |
| 08/14/2008 | US20080193411 Anti-viral Compounds |
| 08/14/2008 | US20080193407 Artificial tears or vehicles for ophthalmic drugs; viscosity; hydroxypropyl methylcellulose and a combination of two other polymers: guar gum, a carboxyvinyl polymer (polymer of acrylic acid crosslinked with allyl sucrose or allylpentaerythritol), hydroxyethyl cellulose or dextran, dry eye |
| 08/14/2008 | US20080193406 enhancing the body's population of beneficial microorganisms like bifido and lactic bacteria for improving health and well-being |
| 08/14/2008 | US20080193398 Sunscreen agents; cosmetic, dermatological, veterinary and pharmaceutical formulations that protect the skin, lips, nails and hair against UV radiation; 2,5,8-tris-(4-(2-ethylhexyloxycarbonyl)phenylamino)-1,3,4,6,7,9,9b-heptaazaphenalene |
| 08/14/2008 | US20080193397 Use of Peroxide Decomposers Method For the Treatment of a Material Other Than the Human Body |
| 08/14/2008 | US20080193394 Reinforcing skin barrier function, suppressing and alleviating inflammatory response, treating and improving atopic skin, activating peroxisome proliferators activated receptors (PPAR) promoting differentiation of the skin, protecting the skin and preventing and improving skin aging and wrinkle |